Ferlay, J., Shin, H.R., Bray, F., Forman, D., Mathers, C., Parkin, D.M., Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 (2010) Int J Cancer, 127, pp. 2893-2917
Hayashi, M., Matsui, O., Ueda, K., Kawamori, Y., Gabata, T., Kadoya, M., Progression to hypervascular hepatocellular carcinoma: Correlation with intranodular blood supply evaluated with CT during intraarterial injection of contrast material (2002) Radiology, 225, pp. 143-149
Braren, R., Curcic, J., Remmele, S., Altomonte, J., Ebert, O., Rummeny, E.J., Free-breathing quantitative dynamic contrast-enhanced magnetic resonance imaging in a rat liver tumor model using dynamic radial T(1) mapping (2011) Invest Radiol, 46, pp. 624-631
Lencioni, R., Llovet, J.M., Modified RECIST (mRECIST) assessment for hepatocellular carcinoma (2010) Semin Liver Dis, 30, pp. 52-60
Zhu, A.X., Duda, D.G., Sahani, D.V., Jain, R.K., HCC and angiogenesis: Possible targets and future directions (2011) Nat Rev Clin Oncol, 8, pp. 292-301
Landis, C.S., Li, X., Telang, F.W., Coderre, J.A., Micca, P.L., Rooney, W.D., Determination of the MRI contrast agent concentration time course in vivo following bolus injection: Effect of equilibrium transcytolemmal water exchange (2000) Magn Reson Med, 44, pp. 563-574
Newell, P., Villanueva, A., Friedman, S.L., Koike, K., Llovet, J.M., Experimental models of hepatocellular carcinoma (2008) J Hepatol, 48, pp. 858-879
Wilhelm, S.M., Adnane, L., Newell, P., Villanueva, A., Llovet, J.M., Lynch, M., Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling (2008) Mol Cancer Ther, 7, pp. 3129-3140
Llovet, J.M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.F., Sorafenib in advanced hepatocellular carcinoma (2008) N Engl J Med, 359, pp. 378-390
Braren, R., Altomonte, J., Settles, M., Neff, F., Esposito, I., Ebert, O., Validation of preclinical multiparametric imaging for prediction of necrosis in hepatocellular carcinoma after embolization (2011) J Hepatol, 55, pp. 1034-1040
Altomonte, J., Braren, R., Schulz, S., Marozin, S., Rummeny, E.J., Schmid, R.M., Synergistic antitumor effects of transarterial viroembolization for multifocal hepatocellular carcinoma in rats (2008) Hepatology, 48, pp. 1864-1873
Abdullah, S.S., Pialat, J.B., Wiart, M., Duboeuf, F., Mabrut, J.Y., Bancel, B., Characterization of hepatocellular carcinoma and colorectal liver metastasis by means of perfusion MRI (2008) J Magn Reson Imaging, 28, pp. 390-395
Aaltonen, L.A., (2000) Pathology and Genetics of Tumours of the Digestive System, 314p. , Lyon Oxford: IARC Press
Oxford University Press (distributor)
Thoolen, B., Maronpot, R.R., Harada, T., Nyska, A., Rousseaux, C., Nolte, T., Proliferative and nonproliferative lesions of the rat and mouse hepatobiliary system (2010) Toxicol Pathol, 38 (7), pp. 5S-81S
Neuvial, P., Hupe, P., Brito, I., Liva, S., Manie, E., Brennetot, C., Spatial normalization of array-CGH data (2006) BMC Bioinformatics, 7, p. 264
Van De Wiel, M.A., Kim, K.I., Vosse, S.J., Van Wieringen, W.N., Wilting, S.M., Ylstra, B., CGHcall: Calling aberrations for array CGH tumor profiles (2007) Bioinformatics, 23, pp. 892-894
Van De-Wiel, M.A., Wieringen, W.N., CGHregions: Dimension reduction for array CGH data with minimal information loss (2007) Cancer Inform, 3, pp. 55-63
Schlaeger, C., Longerich, T., Schiller, C., Bewerunge, P., Mehrabi, A., Toedt, G., Etiology-dependent molecular mechanisms in human hepatocarcinogenesis (2008) Hepatology, 47, pp. 511-520
Wolf, M.J., Adili, A., Piotrowitz, K., Abdullah, Z., Boege, Y., Stemmer, K., Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes (2014) Cancer Cell, 26, pp. 549-564
Heindryckx, F., Colle, I., Van Vlierberghe, H., Experimentalmouse models for hepatocellular carcinoma research (2009) Int J Exp Pathol, 90, pp. 367-386
Wu, L., Tang, Z.Y., Li, Y., Experimental models of hepatocellular carcinoma: Developments and evolution (2009) J Cancer Res Clin Oncol, 135, pp. 969-981
Lee, J.S., Thorgeirsson, S.S., Comparative and integrative functional genomics of HCC (2006) Oncogene, 25, pp. 3801-3809
Polasek, M., Fuchs, B.C., Uppal, R., Schuhle, D.T., Alford, J.K., Loving, G.S., Molecular MR imaging of liver fibrosis: A feasibility study using rat and mouse models (2012) J Hepatol, 57, pp. 549-555
Cho, H.R., Choi, J.W., Kim, H.C., Song, Y.S., Kim, G.M., Son, K.R., Sprague-Dawley rats bearing McA-RH7777 cells for study of hepatoma and transarterial chemoembolization (2013) Anticancer Res, 33, pp. 223-230
Choi, J.W., Kim, H., Kim, H.C., Lee, Y., Kwon, J., Yoo, R.E., Blood oxygen leveldependent MRI for evaluation of early response of liver tumors to chemoembolization: An animal study (2013) Anticancer Res, 33, pp. 1887-1892
Ehling, J., Bartneck, M., Wei, X., Gremse, F., Fech, V., Mockel, D., CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis (2014) Gut, 63, pp. 1960-1971
Coulon, S., Heindryckx, F., Geerts, A., Van Steenkiste, C., Colle, I., Van Vlierberghe, H., Angiogenesis in chronic liver disease and its complications (2011) Liver Int, 31, pp. 146-162
Hoshida, Y., Nijman, S.M., Kobayashi, M., Chan, J.A., Brunet, J.P., Chiang, D.Y., Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma (2009) Cancer Res, 69, pp. 7385-7392
Hoshida, Y., Villanueva, A., Kobayashi, M., Peix, J., Chiang, D.Y., Camargo, A., Gene expression in fixed tissues and outcome in hepatocellular carcinoma (2008) N Engl J Med, 359, pp. 1995-2004
Rutman, A.M., Kuo, M.D., Radiogenomics: Creating a link between molecular diagnostics and diagnostic imaging (2009) Eur J Radiol, 70, pp. 232-241
Segal, E., Sirlin, C.B., Ooi, C., Adler, A.S., Gollub, J., Chen, X., Decoding global gene expression programs in liver cancer by noninvasive imaging (2007) Nat Biotechnol, 25, pp. 675-680
Dong, A., Yu, H., Wang, Y., Dong, H., Zuo, C., FDG PET/CT and enhanced CT imaging of tumor heterogeneity in hepatocellular carcinoma: Imagingpathologic correlation (2014) Clin Nucl Med, 39, pp. 808-810
Kim, K.A., Park, M.S., Ji, H.J., Park, J.Y., Han, K.H., Kim, M.J., Diffusion and perfusion MRI prediction of progression-free survival in patients with hepatocellular carcinoma treated with concurrent chemoradiotherapy (2014) J Magn Reson Imaging, 39, pp. 286-292
Lee, J.H., Lee, J.M., Kim, S.J., Baek, J.H., Yun, S.H., Kim, K.W., Enhancement patterns of hepatocellular carcinomas on multiphasicmultidetector row CT: Comparison with pathological differentiation (2012) Br J Radiol, 85, pp. e573-e583
Stylianopoulos, T., Martin, J.D., Chauhan, V.P., Jain, S.R., Diop-Frimpong, B., Bardeesy, N., Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors Proc Natl Acad Sci U S A, 109, pp. 15101-15108
Jaworski, M., Ittrich, C., Hailfinger, S., Bonin, M., Buchmann, A., Schwarz, M., Global gene expression in Ha-ras and B-raf mutated mouse liver tumors (2007) Int J Cancer, 121, pp. 1382-1385
Horwitz, E., Stein, I., Andreozzi, M., Nemeth, J., Shoham, A., Pappo, O., Human and mouse VEGFA-amplified hepatocellular carcinomas are highly sensitive to sorafenib treatment (2014) Cancer Discov, 4, pp. 730-743
